drplatypus
Bluelighter
Apologies to mods if this is the wrong forum for this- please redirect if need be. I know that there has been some interest in this in the ADD forum...
This paper reports a fatal overdose case involving the potent hallucinogenic drug
Bromo-Dragonfly (1-(8-bromobenzo[1,2-b; 4,5-b']difuran-4-yl)-2-aminopropane). In
the present case, an 18-year-old woman was found dead after ingestion of a
hallucinogenic liquid. A medico-legal autopsy was performed on the deceased,
during which liver, blood, urine and vitreous humour were submitted for
toxicological examination. Bromo-Dragonfly was identified in the liver blood
using UPLC-TOFMS, and was subsequently quantified in femoral blood (0.0047mg/kg),
urine (0.033mg/kg) and vitreous humour (0.0005mg/kg) using LC-MS/MS. Calibration
standards were prepared from Bromo-Dragonfly isolated from a bottle found next to
the deceased. The structure and purity of the isolated compound were
unambiguously determined from analysis of UPLC-TOFMS, GC-MS, HPLC-DAD, (1)H and
(13)C NMR data and by comparison to literature data. The autopsy findings were
non-specific for acute poisoning. However, based on the toxicological findings,
the cause of death was determined to be a fatal overdose of Bromo-Dragonfly, as
no ethanol and no therapeutics or other drugs of abuse besides Bromo-Dragonfly
were detected in the liver, blood or urine samples from the deceased. To our
knowledge, this is the first report of quantification of Bromo-Dragonfly in a
biological specimen from a deceased person. This case caused the drug to be
classified as an illegal drug in Denmark on 5th December 2007.
A fatal poisoning involving Bromo-Dragonfly.
Andreasen MF, Telving R, Birkler RI, Schumacher B, Johannsen M.
Section for Toxicology and Drug Analysis, Institute of Forensic Medicine,
University of Aarhus, Brendstrupgaardsvej 100, DK-8200 Aarhus N, Denmark.
Forensic Sci Int. 2008 Dec 15. [Epub ahead of print]
This paper reports a fatal overdose case involving the potent hallucinogenic drug
Bromo-Dragonfly (1-(8-bromobenzo[1,2-b; 4,5-b']difuran-4-yl)-2-aminopropane). In
the present case, an 18-year-old woman was found dead after ingestion of a
hallucinogenic liquid. A medico-legal autopsy was performed on the deceased,
during which liver, blood, urine and vitreous humour were submitted for
toxicological examination. Bromo-Dragonfly was identified in the liver blood
using UPLC-TOFMS, and was subsequently quantified in femoral blood (0.0047mg/kg),
urine (0.033mg/kg) and vitreous humour (0.0005mg/kg) using LC-MS/MS. Calibration
standards were prepared from Bromo-Dragonfly isolated from a bottle found next to
the deceased. The structure and purity of the isolated compound were
unambiguously determined from analysis of UPLC-TOFMS, GC-MS, HPLC-DAD, (1)H and
(13)C NMR data and by comparison to literature data. The autopsy findings were
non-specific for acute poisoning. However, based on the toxicological findings,
the cause of death was determined to be a fatal overdose of Bromo-Dragonfly, as
no ethanol and no therapeutics or other drugs of abuse besides Bromo-Dragonfly
were detected in the liver, blood or urine samples from the deceased. To our
knowledge, this is the first report of quantification of Bromo-Dragonfly in a
biological specimen from a deceased person. This case caused the drug to be
classified as an illegal drug in Denmark on 5th December 2007.
A fatal poisoning involving Bromo-Dragonfly.
Andreasen MF, Telving R, Birkler RI, Schumacher B, Johannsen M.
Section for Toxicology and Drug Analysis, Institute of Forensic Medicine,
University of Aarhus, Brendstrupgaardsvej 100, DK-8200 Aarhus N, Denmark.
Forensic Sci Int. 2008 Dec 15. [Epub ahead of print]